Meeder Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
31,659
+1,865
| +6% | +$207K | 0.18% | 87 |
|
|
2025
Q1 | $3.34M | Buy |
29,794
+2,049
| +7% | +$230K | 0.2% | 83 |
|
|
2024
Q4 | $2.56M | Buy |
27,745
+2,073
| +8% | +$191K | 0.16% | 104 |
|
|
2024
Q3 | $2.15M | Sell |
25,672
-147
| -0.6% | -$12.3K | 0.14% | 118 |
|
|
2024
Q2 | $1.77M | Buy |
25,819
+3,802
| +17% | +$261K | 0.13% | 133 |
|
|
2024
Q1 | $1.61M | Buy |
22,017
+1,209
| +6% | +$88.6K | 0.16% | 107 |
|
|
2023
Q4 | $1.69M | Buy |
20,808
+585
| +3% | +$47.4K | 0.19% | 89 |
|
|
2023
Q3 | $1.52M | Sell |
20,223
-3,903
| -16% | -$292K | 0.19% | 87 |
|
|
2023
Q2 | $1.86M | Buy |
24,126
+1,761
| +8% | +$136K | 0.2% | 90 |
|
|
2023
Q1 | $1.86M | Buy |
22,365
+1,190
| +6% | +$98.7K | 0.21% | 85 |
|
|
2022
Q4 | $1.82M | Buy |
+21,175
| New | +$1.82M | 0.23% | 81 |
|